Developer docs
API playgroundTry for free, no card

Search company profiles

Rubato

Full company profile

uuid0007ick

Namestring
Rubato
Legal namestring
Rubato, Inc.
Websiteurl
rubato.life
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Rubato is a Los Angeles-based health technology company that has built an AI-driven, physiology-informed music-based intervention (MBI) platform — branded as Rubato Life — for seniors living with dementia, Alzheimer's disease and related dementias (ADRD), and mild cognitive impairment (MCI). The platform continuously monitors real-time cardiac rhythms and stress biomarkers to anticipate behavioral escalation, then uses proprietary music attribute analysis (key, tempo, genre, artist, structure) and a per-patient learning loop to generate personalized therapeutic playlists delivered via tablet. Rubato positions the intervention as fully reimbursable under Medicare Part B through applicable CPT codes, targeting Skilled Nursing Facilities (SNFs), rehabilitation centers, and post-acute care providers as its primary customer base.

The company's go-to-market is a sales-led B2B enterprise motion: Account Executives drive new SNF acquisition through cold outreach, demos, and relationship building with facility administrators, therapy directors, and financial officers, while Clinical Support Specialists deliver hands-on therapist training and onboarding. Clinical credibility is anchored by three academic relationships — an NIH-funded study at Brown University, an anxiety-focused clinical study with Boston University, and a peer-reviewed oncology publication with the University of Illinois — that support broader applicability beyond dementia care.

Rubato generates revenue through B2B facility licensing with a recurring subscription-style structure aligned to Medicare Part B reimbursement cycles, though specific contract values and total revenue are not publicly disclosed. The company was incorporated in Delaware (privacy policy dated December 2019) and is venture-backed following a 2022 round involving Techstars, 97212 Ventures, and The Mercantile Companies; ownership is concentrated in co-founders Amit Sternberg (CEO) and Noam Guy (CTO), supported by a Clinical Advisory board.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLos Angeles, United States
HQ citystring
Los Angeles
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI music therapy, dementia care platform, music-based intervention, physiological monitoring software, skilled nursing technology
Industry2 codes
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAKAIAH
Cognitive & Behavioral Neurology (Dementia/Memory Disorders)
NAICS code2 codes
  • Offices of Physicians, Mental Health Specialists621112
  • Offices of Physical, Occupational and Speech Therapists, and Audiologists62134
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Digital Health / AI Therapeutic Platform for Dementia Care
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Medicare Part B Reimbursement
TypeSubscription Recurring
Description

Rubato's music-based intervention is fully reimbursable for eligible patients at Skilled Nursing Facilities through Medicare Part B using applicable CPT codes. This provides a recurring revenue stream from healthcare facilities treating long-term patients.

rubato.life
2B2B Platform Licensing to Skilled Nursing Facilities
TypeSubscription Recurring
Description

Direct B2B sales of the AI-powered music therapy platform to skilled nursing facilities, rehabilitation centers, and post-acute care providers. Revenue generated through facility licensing and implementation.

rubato.life
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain
Pricing details1 tier
1Reimbursable intervention for Medicare Part B eligible patients
ModelSubscriptionBilling cadenceAnnual
Notes

Fully reimbursable intervention for eligible patients at Skilled Nursing Facilities through applicable CPT codes. Specific pricing not publicly disclosed.

rubato.life
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Rubato sells the Rubato Life platform, an AI-driven, physiology-informed music-based intervention (MBI) that continuously monitors cardiac rhythms and stress biomarkers in dementia and cognitive impairment patients, learns each patient's effective musical attributes, and delivers personalized therapeutic playlists via tablet in Skilled Nursing Facilities. The intervention is fully reimbursable under Medicare Part B through applicable CPT codes and is clinically validated through NIH-funded research at Brown University and clinical studies with Boston University and the University of Illinois.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Significant reduction in stress during pre-post measurement on cancer patients
+4 more records
Product overview1 text field

Rubato offers a single unified product: the Rubato Life platform, an AI-driven music-based intervention (MBI) system. The platform consists of a personalized AI system that analyzes cardiac rhythms and stress levels, evaluates music attributes (key, tempo, genre, artist), and delivers physiology-driven therapeutic music interventions via tablet to support dementia patients in skilled nursing facilities. The intervention is fully reimbursable under Medicare Part B and is backed by clinical outcomes data and research validation from Brown University, Boston University, and University of Illinois.

Product and service1 record
1Rubato Life Platform
CategoryAI Therapeutic Platform / Digital Health Software
Description

AI-driven, physiology-informed music-based intervention (MBI) platform that continuously monitors physiological patterns associated with stress and behavioral escalation, learns which musical attributes (tempo, genre, language, structure) are most effective for each individual patient, and delivers personalized therapeutic playlists via tablet. Sold B2B to Skilled Nursing Facilities and post-acute care providers and fully reimbursable under Medicare Part B via applicable CPT codes for long-term patients.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Rubato is the technology partner in an NIH-funded study at Brown University investigating how real-time physiological patterns can inform timely, responsive music-based interventions for behavioral regulation in dementia care. This is a major validation partnership for the company's clinical approach.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical study with Boston University using STAI questionnaires showed significant improvements in anxiety among participants receiving Rubato's music-based intervention. Research validates the platform's effectiveness in reducing anxiety.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Peer-reviewed study published in a leading oncology journal found that Rubato's intervention helped reduce anxiety and improve quality of life in cancer patients. Study demonstrates broader applicability beyond dementia care.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Constant Therapy delivers a digital cognitive, speech, and language therapy platform used in rehabilitation and skilled nursing settings by occupational, speech, and physical therapists. It overlaps with Rubato on the SNF therapist buyer persona and AI-driven therapy delivery model.

TypeEmerging player
Description

Linus Health offers digital cognitive assessment and brain health platforms focused on early detection of dementia and cognitive impairment. It is comparable as an emerging digital health player targeting the same dementia diagnostic and management pathway.

TypeEmerging player
Description

Altoida develops digital cognitive biomarkers and AI-driven assessments for early detection of Alzheimer's disease and other dementias. It targets the same clinical population (cognitive impairment / dementia) using AI on physiological and behavioral data.

TypeEmerging player
Description

Isaac Health provides dementia-focused virtual care, cognitive assessment, and care navigation services, often partnering with health systems and senior populations. It overlaps with Rubato in the dementia patient population and use of technology-enabled clinical workflows.

TypeDirect peer
Description

Neuroglee develops digital therapeutics specifically for patients with mild cognitive impairment and early dementia, combining software-based cognitive therapy with caregiver support. It targets a similar patient population and clinical indication (cognitive impairment / dementia) using a digital therapeutic delivery model.

TypeBroad incumbent
Description

Posit Science's BrainHQ is an established cognitive training platform used across senior care, health systems, and research settings. It is a broader incumbent in computerized cognitive intervention, overlapping with Rubato's goal of slowing or managing cognitive decline in older adults.

TypeDirect peer
Description

Coro Health provides therapeutic music, video, and wellness content products for senior living, skilled nursing, and hospice settings. It directly competes with Rubato in offering music-based therapeutic content to dementia and cognitive-impairment populations in SNFs.

TypeOthers
Description

Biobeat manufactures wearable remote patient monitoring devices that capture continuous cardiac and physiological biomarkers. Rubato uses similar real-time cardiac rhythm monitoring inputs in its platform, making Biobeat a relevant enabling/infrastructure peer for the physiological monitoring layer.

TypeDirect peer
Description

SingFit is a music therapy platform specifically designed for older adults, including those with dementia, in senior living and care settings. It is the most directly comparable competitor, addressing the same clinical use case (music-based intervention for cognitive and behavioral symptoms) with a similar SNF/senior-care go-to-market motion.

TypeBroad incumbent
Description

Cogstate provides computerized cognitive testing and assessment tools widely used in clinical trials, healthcare, and research for dementia and cognitive impairment. It is a broader incumbent in the cognitive measurement and dementia assessment category that Rubato's clinical workflow touches.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Rubato

Digital Health / AI Therapeutic Platform for Dementia Carerubato.life

What Rubato does

Rubato is a Los Angeles-based health technology company that has built an AI-driven, physiology-informed music-based intervention (MBI) platform — branded as Rubato Life — for seniors living with dementia, Alzheimer's disease and related dementias (ADRD), and mild cognitive impairment (MCI). The platform continuously monitors real-time cardiac rhythms and stress biomarkers to anticipate behavioral escalation, then uses proprietary music attribute analysis (key, tempo, genre, artist, structure) and a per-patient learning loop to generate personalized therapeutic playlists delivered via tablet. Rubato positions the intervention as fully reimbursable under Medicare Part B through applicable CPT codes, targeting Skilled Nursing Facilities (SNFs), rehabilitation centers, and post-acute care providers as its primary customer base.

The company's go-to-market is a sales-led B2B enterprise motion: Account Executives drive new SNF acquisition through cold outreach, demos, and relationship building with facility administrators, therapy directors, and financial officers, while Clinical Support Specialists deliver hands-on therapist training and onboarding. Clinical credibility is anchored by three academic relationships — an NIH-funded study at Brown University, an anxiety-focused clinical study with Boston University, and a peer-reviewed oncology publication with the University of Illinois — that support broader applicability beyond dementia care.

Rubato generates revenue through B2B facility licensing with a recurring subscription-style structure aligned to Medicare Part B reimbursement cycles, though specific contract values and total revenue are not publicly disclosed. The company was incorporated in Delaware (privacy policy dated December 2019) and is venture-backed following a 2022 round involving Techstars, 97212 Ventures, and The Mercantile Companies; ownership is concentrated in co-founders Amit Sternberg (CEO) and Noam Guy (CTO), supported by a Clinical Advisory board.

Rubato firmographics

Firmographics
Name
Rubato
Legal name
Rubato, Inc.
Website
https://rubato.life
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Rubato industry classification

Industry
Product category
Digital Health / AI Therapeutic Platform for Dementia Care
NAICS
Offices of Physicians, Mental Health Specialists (621112), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLALAFAF
Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs)
Healthcare & Life Sciences/Telehealth Platforms/Chronic Care & Remote Patient Monitoring (RPM) Platforms
SECONDARYHLAKAIAH
Cognitive & Behavioral Neurology (Dementia/Memory Disorders)

Keywords

  • AI music therapy
  • Dementia care platform
  • Music-based intervention
  • Physiological monitoring software
  • Skilled nursing technology

Where Rubato is headquartered

Location

Headquarters

HQ city
Los Angeles
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Rubato business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Supply Chain

Revenue model

  1. Medicare Part B Reimbursement: Rubato's music-based intervention is fully reimbursable for eligible patients at Skilled Nursing Facilities through Medicare Part B using applicable CPT codes. This provides a recurring revenue stream from healthcare facilities treating long-term patients.
  2. B2B Platform Licensing to Skilled Nursing Facilities: Direct B2B sales of the AI-powered music therapy platform to skilled nursing facilities, rehabilitation centers, and post-acute care providers. Revenue generated through facility licensing and implementation.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualReimbursable intervention for Medicare Part B eligible patients

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

Rubato product offering

Product offering

Core offering

Rubato sells the Rubato Life platform, an AI-driven, physiology-informed music-based intervention (MBI) that continuously monitors cardiac rhythms and stress biomarkers in dementia and cognitive impairment patients, learns each patient's effective musical attributes, and delivers personalized therapeutic playlists via tablet in Skilled Nursing Facilities. The intervention is fully reimbursable under Medicare Part B through applicable CPT codes and is clinically validated through NIH-funded research at Brown University and clinical studies with Boston University and the University of Illinois.

Product overview

Rubato offers a single unified product: the Rubato Life platform, an AI-driven music-based intervention (MBI) system. The platform consists of a personalized AI system that analyzes cardiac rhythms and stress levels, evaluates music attributes (key, tempo, genre, artist), and delivers physiology-driven therapeutic music interventions via tablet to support dementia patients in skilled nursing facilities. The intervention is fully reimbursable under Medicare Part B and is backed by clinical outcomes data and research validation from Brown University, Boston University, and University of Illinois.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rubato Life Platform AI-driven, physiology-informed music-based intervention (MBI) platform that continuously monitors physiological patterns associated with stress and behavioral escalation, learns which musical attributes (tempo, genre, language, structure) are most effective for each individual patient, and delivers personalized therapeutic playlists via tablet. Sold B2B to Skilled Nursing Facilities and post-acute care providers and fully reimbursable under Medicare Part B via applicable CPT codes for long-term patients.

Quantifiable outcome

  • Significant reduction in stress during pre-post measurement on cancer patients
  • +4 more outcomes

Companies that use Rubato

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Rubato technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature4 records

Rubato partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered flagship and core.

  • Brown UniversityflagshipStrategic or Co-development PartnerRubato is the technology partner in an NIH-funded study at Brown University investigating how real-time physiological patterns can inform timely, responsive music-based interventions for behavioral regulation in dementia care. This is a major validation partnership for the company's clinical approach.
  • Boston UniversitycoreStrategic or Co-development PartnerClinical study with Boston University using STAI questionnaires showed significant improvements in anxiety among participants receiving Rubato's music-based intervention. Research validates the platform's effectiveness in reducing anxiety.
  • University of IllinoiscoreStrategic or Co-development PartnerPeer-reviewed study published in a leading oncology journal found that Rubato's intervention helped reduce anxiety and improve quality of life in cancer patients. Study demonstrates broader applicability beyond dementia care.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Rubato competitors and assessment

Company assessment

Direct peers

  • Constant Therapy Health: Constant Therapy delivers a digital cognitive, speech, and language therapy platform used in rehabilitation and skilled nursing settings by occupational, speech, and physical therapists. It overlaps with Rubato on the SNF therapist buyer persona and AI-driven therapy delivery model.
  • Neuroglee Therapeutics: Neuroglee develops digital therapeutics specifically for patients with mild cognitive impairment and early dementia, combining software-based cognitive therapy with caregiver support. It targets a similar patient population and clinical indication (cognitive impairment / dementia) using a digital therapeutic delivery model.
  • Coro Health: Coro Health provides therapeutic music, video, and wellness content products for senior living, skilled nursing, and hospice settings. It directly competes with Rubato in offering music-based therapeutic content to dementia and cognitive-impairment populations in SNFs.
  • Musical Health Technologies (SingFit): SingFit is a music therapy platform specifically designed for older adults, including those with dementia, in senior living and care settings. It is the most directly comparable competitor, addressing the same clinical use case (music-based intervention for cognitive and behavioral symptoms) with a similar SNF/senior-care go-to-market motion.

Emerging players

  • Linus Health: Linus Health offers digital cognitive assessment and brain health platforms focused on early detection of dementia and cognitive impairment. It is comparable as an emerging digital health player targeting the same dementia diagnostic and management pathway.
  • Altoida: Altoida develops digital cognitive biomarkers and AI-driven assessments for early detection of Alzheimer's disease and other dementias. It targets the same clinical population (cognitive impairment / dementia) using AI on physiological and behavioral data.
  • Isaac Health: Isaac Health provides dementia-focused virtual care, cognitive assessment, and care navigation services, often partnering with health systems and senior populations. It overlaps with Rubato in the dementia patient population and use of technology-enabled clinical workflows.

Broad incumbents

  • Posit Science (BrainHQ): Posit Science's BrainHQ is an established cognitive training platform used across senior care, health systems, and research settings. It is a broader incumbent in computerized cognitive intervention, overlapping with Rubato's goal of slowing or managing cognitive decline in older adults.
  • Cogstate: Cogstate provides computerized cognitive testing and assessment tools widely used in clinical trials, healthcare, and research for dementia and cognitive impairment. It is a broader incumbent in the cognitive measurement and dementia assessment category that Rubato's clinical workflow touches.

Others

  • Biobeat: Biobeat manufactures wearable remote patient monitoring devices that capture continuous cardiac and physiological biomarkers. Rubato uses similar real-time cardiac rhythm monitoring inputs in its platform, making Biobeat a relevant enabling/infrastructure peer for the physiological monitoring layer.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Rubato social profiles

Digital presence

Rubato financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Rubato leadership team

Management profile

Number of profiles

Profiles2 records

Rubato funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Rubato M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Rubato

What does Rubato do?

Rubato sells the Rubato Life platform, an AI-driven, physiology-informed music-based intervention (MBI) that continuously monitors cardiac rhythms and stress biomarkers in dementia and cognitive impairment patients, learns each patient's effective musical attributes, and delivers personalized therapeutic playlists via tablet in Skilled Nursing Facilities. The intervention is fully reimbursable under Medicare Part B through applicable CPT codes and is clinically validated through NIH-funded research at Brown University and clinical studies with Boston University and the University of Illinois.

Is Rubato a public or private company?

Rubato is a private company. It is classified as venture growth investor backed and is currently operating.

When was Rubato founded?

Rubato was founded in 2020. It employs 11 to 50 people.

Where is Rubato based?

Rubato is headquartered in Los Angeles, United States, in the North America region.

How does Rubato make money?

Two revenue lines are on record. Medicare Part B Reimbursement is the primary driver. The others are B2B Platform Licensing to Skilled Nursing Facilities.

Who are Rubato's main competitors?

Direct peers on record are Constant Therapy Health, Neuroglee Therapeutics, Coro Health and Musical Health Technologies (SingFit). Emerging players are Linus Health, Altoida and Isaac Health. Broad incumbents are Posit Science (BrainHQ) and Cogstate. Biobeat is listed as an others.

Does Rubato have an API?

No public API is recorded for Rubato.

What industry is Rubato in?

Rubato's product category is Digital Health / AI Therapeutic Platform for Dementia Care. Its primary akta.pro industry code is HLALAFAF, Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs), with a secondary code of HLAKAIAH, Cognitive & Behavioral Neurology (Dementia/Memory Disorders). Its NAICS code is 621112 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales